Hostelworld vs Tango Therapeutics

Hostelworld and Tango Therapeutics are two vastly different companies operating in completely separate industries. Hostelworld is a leading online booking platform for budget accommodations around the world, catering mostly to budget travelers and backpackers. On the other hand, Tango Therapeutics is a biotechnology company focused on developing innovative treatments for cancer using cutting-edge technology. Both companies have seen fluctuations in their stock prices due to various factors, making them interesting options for investors seeking growth potential.

Hostelworld

Tango Therapeutics

Stock Price
Day Low€1.55
Day High€1.75
Year Low€1.20
Year High€2.00
Yearly Change66.67%
Revenue
Revenue Per Share€0.73
5 Year Revenue Growth-0.13%
10 Year Revenue Growth0.25%
Profit
Gross Profit Margin0.33%
Operating Profit Margin0.11%
Net Profit Margin0.16%
Stock Price
Day Low$6.75
Day High$7.01
Year Low$6.32
Year High$13.01
Yearly Change105.78%
Revenue
Revenue Per Share$0.39
5 Year Revenue Growth-0.86%
10 Year Revenue Growth-0.86%
Profit
Gross Profit Margin0.94%
Operating Profit Margin-3.12%
Net Profit Margin-2.74%

Hostelworld

Tango Therapeutics

Financial Ratios
P/E ratio14.44
PEG ratio-5.41
P/B ratio3.50
ROE24.88%
Payout ratio0.00%
Current ratio0.43
Quick ratio0.43
Cash ratio0.22
Dividend
Dividend Yield-%
5 Year Dividend Yield0.00%
10 Year Dividend Yield0.00%
Hostelworld Dividend History
Financial Ratios
P/E ratio-6.42
PEG ratio0.06
P/B ratio3.02
ROE-44.73%
Payout ratio0.00%
Current ratio7.49
Quick ratio7.49
Cash ratio1.18
Dividend
Dividend Yield-%
5 Year Dividend Yield0.00%
10 Year Dividend Yield0.00%
Tango Therapeutics Dividend History

Hostelworld or Tango Therapeutics?

When comparing Hostelworld and Tango Therapeutics, different investors may prioritize various metrics based on their investment strategies and goals. So, ask yourself what type of investor you are. This will guide you in determining which metrics are most important for your investment decision between Hostelworld and Tango Therapeutics.

Dividend Investors:

Dividend investors look for stable and growing income streams, using dividend metrics to assess potential investments. A company's dividend yield essentially measures the size of its dividend relative to the total market value of the company. Hostelworld has a dividend yield of -%, while Tango Therapeutics has a dividend yield of -%. Beyond the yield itself, considering the growth and sustainability of these dividends is also crucial. Hostelworld reports a 5-year dividend growth of 0.00% year and a payout ratio of 0.00%. On the other hand, Tango Therapeutics reports a 5-year dividend growth of 0.00% year and a payout ratio of 0.00%.

Value Investors:

Value investors focus on financial metrics to determine a stock's intrinsic value compared to its market value. The Price-to-Earnings (P/E) Ratio links stock price to a company's earnings per share, with Hostelworld P/E ratio at 14.44 and Tango Therapeutics's P/E ratio at -6.42. Another crucial valuation metric is the Price-to-Book (P/B) Ratio, which compares stock price with book value per share. Hostelworld P/B ratio is 3.50 while Tango Therapeutics's P/B ratio is 3.02.

Growth Investors:

Growth investors prioritize metrics indicative of a company's expansion potential. Focusing on top-line growth, Hostelworld has seen a 5-year revenue growth of -0.13%, while Tango Therapeutics's is -0.86%. Return on Equity (ROE) measures how effectively a company uses equity investment to generate earnings, with Hostelworld's ROE at 24.88% and Tango Therapeutics's ROE at -44.73%.

Retail Investors:

Retail investors often consider stock affordability and company familiarity. For example, day low prices are €1.55 for Hostelworld and $6.75 for Tango Therapeutics. Over the past year, Hostelworld's prices ranged from €1.20 to €2.00, with a yearly change of 66.67%. Tango Therapeutics's prices fluctuated between $6.32 and $13.01, with a yearly change of 105.78%. Brand recognition also plays a role, as familiarity with a company can influence investment decisions.

Comparision